249 related articles for article (PubMed ID: 15880818)
1. Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis.
Djouad F; Fritz V; Apparailly F; Louis-Plence P; Bony C; Sany J; Jorgensen C; Noël D
Arthritis Rheum; 2005 May; 52(5):1595-603. PubMed ID: 15880818
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
[TBL] [Abstract][Full Text] [Related]
3. Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis.
Augello A; Tasso R; Negrini SM; Cancedda R; Pennesi G
Arthritis Rheum; 2007 Apr; 56(4):1175-86. PubMed ID: 17393437
[TBL] [Abstract][Full Text] [Related]
4. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells.
González MA; Gonzalez-Rey E; Rico L; Büscher D; Delgado M
Arthritis Rheum; 2009 Apr; 60(4):1006-19. PubMed ID: 19333946
[TBL] [Abstract][Full Text] [Related]
5. TNF-alpha and IL-1beta inhibit RUNX2 and collagen expression but increase alkaline phosphatase activity and mineralization in human mesenchymal stem cells.
Ding J; Ghali O; Lencel P; Broux O; Chauveau C; Devedjian JC; Hardouin P; Magne D
Life Sci; 2009 Apr; 84(15-16):499-504. PubMed ID: 19302812
[TBL] [Abstract][Full Text] [Related]
6. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation.
Le Blanc K; Ringdén O
Biol Blood Marrow Transplant; 2005 May; 11(5):321-34. PubMed ID: 15846285
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulation by mesenchymal stem cells and clinical experience.
Le Blanc K; Ringdén O
J Intern Med; 2007 Nov; 262(5):509-25. PubMed ID: 17949362
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive properties of cloned bone marrow mesenchymal stem cells.
Xu G; Zhang L; Ren G; Yuan Z; Zhang Y; Zhao RC; Shi Y
Cell Res; 2007 Mar; 17(3):240-8. PubMed ID: 17325691
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stromal cells lose their immunosuppressive potential after allotransplantation.
Prigozhina TB; Khitrin S; Elkin G; Eizik O; Morecki S; Slavin S
Exp Hematol; 2008 Oct; 36(10):1370-6. PubMed ID: 18619727
[TBL] [Abstract][Full Text] [Related]
10. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease.
Yañez R; Lamana ML; García-Castro J; Colmenero I; Ramírez M; Bueren JA
Stem Cells; 2006 Nov; 24(11):2582-91. PubMed ID: 16873762
[TBL] [Abstract][Full Text] [Related]
11. A role for mesenchymal stem cells in the control of graft-versus-host disease.
Cohen JL; Sudres M
Transplantation; 2009 May; 87(9 Suppl):S53-4. PubMed ID: 19424007
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive effects of rat mesenchymal stem cells: involvement of CD4+CD25+ regulatory T cells.
Ye Z; Wang Y; Xie HY; Zheng SS
Hepatobiliary Pancreat Dis Int; 2008 Dec; 7(6):608-14. PubMed ID: 19073406
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cell therapy for degenerative inflammatory disorders.
Müller I; Lymperi S; Dazzi F
Curr Opin Organ Transplant; 2008 Dec; 13(6):639-44. PubMed ID: 19060556
[TBL] [Abstract][Full Text] [Related]
14. Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute.
Bernardo ME; Avanzini MA; Perotti C; Cometa AM; Moretta A; Lenta E; Del Fante C; Novara F; de Silvestri A; Amendola G; Zuffardi O; Maccario R; Locatelli F
J Cell Physiol; 2007 Apr; 211(1):121-30. PubMed ID: 17187344
[TBL] [Abstract][Full Text] [Related]
15. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
[TBL] [Abstract][Full Text] [Related]
16. Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues.
Yoo KH; Jang IK; Lee MW; Kim HE; Yang MS; Eom Y; Lee JE; Kim YJ; Yang SK; Jung HL; Sung KW; Kim CW; Koo HH
Cell Immunol; 2009; 259(2):150-6. PubMed ID: 19608159
[TBL] [Abstract][Full Text] [Related]
17. A tumor necrosis factor receptor loop peptide mimic inhibits bone destruction to the same extent as anti-tumor necrosis factor monoclonal antibody in murine collagen-induced arthritis.
Saito H; Kojima T; Takahashi M; Horne WC; Baron R; Amagasa T; Ohya K; Aoki K
Arthritis Rheum; 2007 Apr; 56(4):1164-74. PubMed ID: 17393436
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive properties of mesenchymal stem cells derived from bone marrow of patients with chronic myeloid leukemia.
Zhao ZG; Li WM; Chen ZC; You Y; Zou P
Immunol Invest; 2008; 37(7):726-39. PubMed ID: 18821219
[TBL] [Abstract][Full Text] [Related]
19. IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury.
Banas A; Teratani T; Yamamoto Y; Tokuhara M; Takeshita F; Osaki M; Kawamata M; Kato T; Okochi H; Ochiya T
Stem Cells; 2008 Oct; 26(10):2705-12. PubMed ID: 18535155
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic murine mesenchymal stem cells: migration to inflamed joints in vivo and amelioration of collagen induced arthritis when transduced to express CTLA4Ig.
Sullivan C; Barry F; Ritter T; O'Flatharta C; Howard L; Shaw G; Anegon I; Murphy M
Stem Cells Dev; 2013 Dec; 22(24):3203-13. PubMed ID: 23895495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]